Uniasia Closer to IPO in A Share
- Chaileedo Press
- Dec 28, 2022
- 2 min read
More than a year after launching its IPO plan, Guangzhou Uniasia Cosmetics Technology Co. Ltd.(hereinafter Uniasia) has made new progress in its IPO.
On December 22, 2022, Uniasia IPO passed the counseling acceptance of China Guangdong Securities Regulatory Commission .
Among the current Chinese beauty companies, Shanghai Jahwa, PROYA, BTN, Giant Biogene and Chicmax have landed in the capital market. With the new progress of the IPO of Uniasia, the sector of Chinese domestic beauty listing is also becoming more and more competitive, such as MAOGEPING, INOHERB, Trauer, Voolga, WeiMeiZi, Dencare and other related enterprises are in the process of IPO.
It is foreseeable that with the listing of this group of enterprises, the voice of Chinese domestic beauty in the Chinese cosmetics market will be further enhanced.
Public information shows that Uniasia was established in February 2006. At present, it has more than ten brands, including MEIFUBAO, Franic, Seeyoung, SkynFuture, GITTAMY, MOR, MOINA, etc., covering several product areas such as skin care, shampoo and hair care, body care, essential oils and color cosmetics.
But in fact, its cosmetics business has been launched as early as the 1990s. Uniasia’s first brand, MEIFUBAO, was born in 1999. According to public information, as of August 2022, sales of MEIFUBAO sunscreen products grew by 10% relative to 2021. According to the research data of Euromonitor (Shanghai) Co., in the mainland China market, according to the sales of retail channels in 2020, MEIFUBAO is the No. 1 Chinese sunscreen brand in China. It has been the Top 1 in the sunscreen category in China cosmetic category ranking for 8 consecutive years.
The success of brand building is inevitably dependent on the company's investment in product building and research and development. Uniasia was one of the first companies to establish a large research institute, and its China headquarters research institute was established in 2007. At present, Uniasia has established two major R&D centers in China and Australia.
As of November 2022, Uniasia has obtained 157 authorized patents, including 87 invention patents, 20 utility models and 50 designs. It gained 30 scientific and technological progress awards at all levels and more than 100 scientific and technological academic papers have been published. At present, Uniasia's R&D staff has successfully created innovative ingredients such as 799 Reishiin, 1543 sea fennel ferment and 204 aloe vera ferment, which have been applied in core products such as VITALXI, SkynFuture and Franic.
This is not the first time that Uniasia has included IPO in its schedule. It is reported that Uniasia tried to go public in Hong Kong as early as 2011. Now, after eleven years, Uniasia has once again launched IPO, showing a stronger strength than in the past.
Comments